The opening session featured a panel demonstrating the life cycle of innovation. This panel captured the story of MAKO Surgical, a startup company meshing custom knee replacement implants with robotic precision in surgery. Participating in the panel, from left, is Sid Martin Biotech Director Mark Long (as moderator), Dr. Scott Banks (the inventor of the implants), Dr. Maurice Ferre (the founder and original CEO of MAKO), Dr. Tony Natale (original investor in the company), Dr. Tristan Altbuch (orthopaedic surgeon who uses Makoplasty, as the combination of custom implants and robotic precision is called), and Dr. John Byatt (the licensing officer who created the license that moved the technology from the lab into the marketplace where it could make the world a better place). The technology was purchased by Stryker for $1.65 billion. Audience members had an opportunity to ask questions of the panelists.